Nov. 18, 2026 — Nanox Imaging Ltd. will showcase technologies designed to enable earlier detection and broader access to care at RSNA 2026 meeting in Chicago.
At RSNA 2026, attendees can explore the full Nanox platform, including:
- Nanox.ARC X, an FDA-cleared, multi-source digital tomosynthesis system powered by proprietary digital X-ray technology and designed to make advanced 3D imaging accessible in more clinical settings; live demonstrations will be featured at Nanox’s booth
- FDA-cleared, AI-powered algorithms that analyze routine CT scans to identify early signs of chronic conditions
- Teleradiology services from USARAD and health IT services from Nanox Health IT that help ensure imaging insights reach the right clinicians and become part of the care pathway
“Innovation is at the core of what we build at Nanox, from the proprietary digital X-ray technology behind Nanox.ARC X, which TIME named one of its Best Inventions of 2026, to AI that helps clinicians identify early signs of chronic disease in routine CT scans. At RSNA, we're showing what Nanox offers today and previewing what we're developing next, all with one goal: to enable earlier detection and broaden access to care," said Erez Meltzer, chief executive officer.
“Medical imaging contains far more information than is often captured,” said Lawrence Tanenbaum, MD, chief medical officer, U.S., Nanox. “We are demonstrating how our innovative technology can unlock more of that information, from the advanced capabilities of the Nanox.ARC X to identifying additional health insights from routine CT scans with Nanox.AI.”
More details about Nanox’s RSNA 2026 presentations:
Industry Expert Theater Presentation: "See What Matters: How the Next Generation of Imaging Can Reveal More, Expand Access, and Drive Care Forward" presented by Erez Meltzer (CEO) and Lawrence Tanenbaum, MD (Chief Medical Officer, U.S., Nanox)
Innovation Theater Presentation: "From Routine Chest CT to Cardiovascular Insight: AI-Powered AVC Assessment" presented by Ofir Koren, MD, FACC, FESC (Ofir Koren, MD, FACC, FESC, Assistant Professor of Cardiology, Director, Cardiovascular Innovation Program of Cedars-Sinai Medical Center, consultant to Nanox.AI and lead author of the study.)
To learn more go to www.nanox.vision/rsna2026

November 19, 2026 